Researchers working in the clinical laboratory

Prof. Stéphanie Ruphy: Research integrity is about trust

Dr Stéphanie Ruphy is Professor of philosophy of science at the École normale supérieure - Université PSL in Paris. She is currently the Director of the French Office for Research Integrity. She recently helped draft a research integrity oath for Ph.D.s in France. We discuss with her research ethics and integrity in practice. Most people ...

Close up of math formulas on a blackboard

Prof. Maryna Viazovska: ‘Science is a dream of the future and a refuge for the soul’

In July 2022, mathematician Prof. Maryna Viazovska received a Fields Medal, a prestigious honour often described as the 'Nobel Prize of Mathematics'. The 37-year-old professor, who works at the Swiss Federal Institute of Technology in Lausanne, is the second woman to receive this prestigious award in the 86-year history of the prize. We spoke to ...

The panelists Brian Schmidt, María Miserendino, Antje Boetius, Sophie Gutenthaler, Venki Ramakrishnan & moderator Adam Smith discuss public trust in Science, trust in Chemistry during the 71 st Lindau Nobel laureate meeting in Germany in May.

Between truth and trust – young and established scientists discuss public trust in research

The pandemic has changed a lot in our society, including the perception of science by the general public, politicians and governments. The general media has increasingly covered science news during the rise of the health crisis. Shortly after the start of the coronavirus outbreak, public confidence in scientists increased according to a May 2020 survey. ...

The new European Bauhaus a better future together

The new European Bauhaus: a better future together

The New European Bauhaus (NEB) project was initiated to carry the values of the European Green Deal. It is an interdisciplinary approach in which technology, design, art and science combine forces to build a more sustainable, enriching and inclusive future. In this context, the European Parliament's Panel for the Future of Science and Technology ...

Ampules, syringe, tablets and spray

Massimo Florio: could a ‘European Medicines Infrastructure’ solve market failures in pharmaceutical R&D?

Interview with Massimo Florio (Professor of Public Economics, University of Milan, Italy) about a new European approach to pharmaceutical policy. In response to the Covid-19 crisis, the European Union has increased its commitment to the EU public health agenda. It has strengthened the mandate of both the European Medicines Agency (EMA) and the European Centre ...

Low poly brain illustration isolated on blue BG

Edvard Moser: “Neuroscience is evolving at an accelerated speed”

Interview with Prof. Edvard Moser. On 12 October, the Panel for the Future of Science and Technology (STOA), in collaboration with the International Brain Initiative (IBI) and the Kavli Foundation, organised a workshop at the European Parliament entitled "The International Brain Initiative – Shaping the future of globally coordinated neuroscience”. Keynote speaker was Prof Edvard ...

Low poly brain illustration isolated on blue BG

Jan Bjaalie on international brain research: “We are now in a critical phase”

One of its leading experts is Jan Bjaalie, Professor at the University of Oslo. He talks to us about his work bringing local brain initiatives together, the future of brain research, artificial intelligence and the challenges European neuroscience is facing. “Catalysing and advancing neuroscience research through international collaboration and knowledge sharing. Uniting diverse ambitions to ...

Coronavirus mutation vector background with disease molecules on blue. Medical research or pandemic virus prevention banner with COVID-19 abstract images under microscope. Europe coronavirus mutation

SARS-CoV-2: the challenges of mutation and possible strategies

The efficacy of the current COVID-19 vaccines might be lower against the new variants of SARS-CoV-2. The new strain that emerged in the United Kingdom has a higher transmissibility than previous strains of the virus. We asked scientists whether the new mutations are a threat to the current public health measures and to COVID-19 vaccines.